Profile data is unavailable for this security.
About the company
Finch Therapeutics Group, Inc. is a microbiome technology company with a portfolio of intellectual property and microbiome assets. It is focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations. It has an intellectual property estate, including more than 113 issued U.S. and foreign patents with relevance for both donor-derived and donor-independent microbiome therapeutics in a range of potential indications. Its assets include CP101, an orally administered microbiome candidate designed for the prevention of recurrent C. difficile infection (CDI), with positive clinical data from a Phase II randomized, placebo-controlled trial and a Phase II open-label trial, and pre-clinical assets that are designed to target ulcerative colitis, Crohn’s disease, and autism spectrum disorder. Additionally, it has also developed a biorepository of strains and samples.
- Revenue in USD (TTM)0.00
- Net income in USD-14.17m
- Incorporated2017
- Employees18.00
- LocationFinch Therapeutics Group Inc75 State Street, Suite 100BOSTON 02109United StatesUSA
- Phone+1 (617) 229-6499
- Fax+1 (302) 636-5454
- Websitehttps://finchtherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tenax Therapeutics Inc | 0.00 | -14.56m | 16.53m | 5.00 | -- | 0.17 | -- | -- | -15.92 | -15.92 | 0.00 | 28.52 | 0.00 | -- | -- | 0.00 | -26.08 | -199.16 | -26.84 | -285.64 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 30.21 | -- | -- | -- |
| Kazia Therapeutics Ltd (ADR) | 14.69k | -13.32m | 17.11m | 12.00 | -- | 0.1607 | -- | 1,164.92 | -80.82 | -80.82 | 0.0797 | 34.41 | 0.0007 | -- | 73.97 | -- | -63.98 | -46.35 | -82.39 | -54.75 | -- | -- | -90,714.45 | -497.17 | -- | -- | 0.1297 | -- | 979.43 | -28.31 | 18.19 | -- | -- | -- |
| Bullfrog AI Holdings, Inc. | 0.00 | -6.59m | 17.51m | 4.00 | -- | 4.13 | -- | -- | -0.8556 | -0.8556 | 0.00 | 0.487 | 0.00 | -- | -- | 0.00 | -149.16 | -- | -173.23 | -- | -- | -- | -- | -- | -- | -370.56 | 0.043 | -- | 550.00 | -- | -91.11 | -- | -- | -- |
| Cognition Therapeutics Inc | 0.00 | -34.27m | 17.65m | 25.00 | -- | 1.24 | -- | -- | -0.9553 | -0.9553 | 0.00 | 0.3549 | 0.00 | -- | -- | 0.00 | -103.30 | -- | -150.91 | -- | -- | -- | -- | -- | -- | -260.86 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
| NanoViricides Inc | 0.00 | -9.45m | 17.85m | 7.00 | -- | 1.78 | -- | -- | -0.7579 | -0.7579 | 0.00 | 0.7188 | 0.00 | -- | -- | 0.00 | -69.61 | -43.88 | -76.92 | -46.26 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.43 | -- | 16.23 | -- |
| Neurosense Therapeutics Ltd | 0.00 | -7.51m | 17.91m | 16.00 | -- | -- | -- | -- | -0.4392 | -0.4392 | 0.00 | -0.0943 | 0.00 | -- | -- | 0.00 | -154.72 | -- | -470.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 18.10 | -- | -- | -- |
| OpGen Inc | 1.96m | -22.39m | 18.22m | 100.00 | -- | -- | -- | 9.27 | -20.01 | -20.01 | 1.66 | -8.65 | 0.1553 | -- | 6.09 | -- | -176.99 | -87.95 | -15,455.17 | -127.65 | 3.15 | 15.42 | -1,139.66 | -794.78 | -- | -20.25 | -- | -- | 31.11 | 3.02 | 12.38 | -- | 40.20 | -- |
| Palatin Technologies, Inc. | 2.38m | -32.35m | 18.35m | 30.00 | -- | -- | -- | 7.70 | -1.98 | -1.98 | 0.1434 | -0.3932 | 0.3252 | -- | -- | 79,470.34 | -441.31 | -55.28 | -- | -69.08 | 95.90 | -- | -1,357.06 | -1,359.14 | -- | -- | -- | -- | -7.49 | -40.52 | -23.71 | -- | 3.31 | -- |
| Finch Therapeutics Group Inc | 0.00 | -14.17m | 18.39m | 18.00 | -- | 1.29 | -- | -- | -8.82 | -8.82 | 0.00 | 8.86 | 0.00 | -- | -- | -- | -25.20 | -- | -28.80 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -87.57 | -- | 34.80 | -- | -- | -- |
| Mira Pharmaceuticals Inc | 0.00 | -11.24m | 18.62m | 3.00 | -- | 5.73 | -- | -- | -0.7287 | -0.7287 | 0.00 | 0.2197 | 0.00 | -- | -- | 0.00 | -169.22 | -- | -191.76 | -- | -- | -- | -- | -- | -- | -3.32 | 0.00 | -- | -- | -- | -69.77 | -- | -- | -- |
| MEI Pharma Inc | 0.00 | -46.60m | 18.72m | 28.00 | -- | 0.7526 | -- | -- | -6.99 | -6.99 | 0.00 | 3.73 | 0.00 | -- | -- | 0.00 | -72.25 | -21.09 | -79.28 | -23.99 | -- | -- | -- | -72.23 | -- | -- | 0.00 | -- | 33.76 | 67.75 | 155.84 | -- | -49.68 | -- |
| Kairos Pharma Ltd | 0.00 | -2.74m | 19.26m | -- | -- | 5.78 | -- | -- | -0.2279 | -0.2279 | 0.00 | 0.2594 | 0.00 | -- | -- | -- | -92.10 | -- | -264.70 | -- | -- | -- | -- | -- | -- | -2.61 | 0.0409 | -- | -- | -- | -72.57 | -- | -- | -- |
| Unity Biotechnology Inc | 0.00 | -19.05m | 19.55m | 19.00 | -- | 1.38 | -- | -- | -1.14 | -1.14 | 0.00 | 0.8394 | 0.00 | -- | -- | 0.00 | -32.73 | -47.21 | -38.49 | -53.51 | -- | -- | -- | -6,395.92 | -- | -- | 0.00 | -- | -100.00 | -- | 10.36 | -- | -61.28 | -- |
| Goldenwell Biotech Inc | 940.00 | -137.11k | 19.80m | -- | -- | 5,169.71 | -- | 21,063.83 | -0.0014 | -0.0014 | 0.00001 | 0.00004 | 0.0048 | 0.0031 | -- | -- | -69.82 | -- | -70.29 | -- | 42.55 | -- | -14,586.17 | -- | 21.43 | -- | 0.00 | -- | -95.10 | -- | 88.13 | -- | -- | -- |
| Neurobo Pharmaceuticals Inc | 0.00 | -27.73m | 20.25m | 8.00 | -- | 1.56 | -- | -- | -4.77 | -4.77 | 0.00 | 1.50 | 0.00 | -- | -- | 0.00 | -114.20 | -95.57 | -159.68 | -135.64 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 10.72 | -- | 75.54 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Aperture Investors LLCas of 30 Sep 2021 | 3.96k | 0.25% |
| Guggenheim Partners Investment Management LLCas of 31 Aug 2024 | 1.00 | 0.00% |
| Bain Capital Public Equity LPas of 08 Jun 2023 | 0.00 | 0.00% |
| Lake Street Advisors Group LLCas of 30 Sep 2024 | 0.00 | 0.00% |
